Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Gut resistome linked to sexual preference and HIV infection.
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes.
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection and Humoral Responses Against Different Variants of Concern in Domestic Pet Animals and Stray Cats from North-Eastern Spain.
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression.